Low Incidence and Successful Treatment of Post-Transplant Lymphoproliferative Disorders (PTLD) among 1,513 Patients Undergoing Liver Transplant Procedures.

Corrado Tarella(European Institute of Oncology), Mauro Salizzoni(Azienda Ospedaliero Universitaria San Giovanni Battista), Renato Romagnoli(University of Turin), Ornella Perotto(Istituto Tecnico Industriale Alessandro Volta), A Franchello(Istituto Tecnico Industriale Alessandro Volta), Roberto Passera(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino)
Blood
November 16, 2007
10.1182/blood.v110.11.513.513
Cited by 1

Related Papers

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
The genomic landscape of response to EGFR blockade in colorectal cancer
|Nature|2015|495
Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial
|Blood|2007|307
Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders
|Leukemia|2013|305
Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients
|Blood|2011|268